Company Overview of Promentis Pharmaceuticals, Inc.
Promentis Pharmaceuticals Inc. discover, develop and market new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals Inc. was founded in 2006 and is based in Milwaukee, Wisconsin.
826 North Plankinton Avenue
Milwaukee, WI 53203
Founded in 2006
Key Executives for Promentis Pharmaceuticals, Inc.
Chief Executive Officer and President
Compensation as of Fiscal Year 2015.
Promentis Pharmaceuticals, Inc. Key Developments
Promentis Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 04:45 PM
Dec 18 14
Promentis Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 04:45 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Promentis Pharmaceuticals, Inc. Appoints Chad Beyer as President and Chief Executive Officer
Jul 25 13
Promentis Pharmaceuticals, Inc. announced that Chad Beyer, Ph.D., MBA, has been appointed as President and Chief Executive Officer. With nearly 20 years experience, Dr. Beyer's career encompasses research, discovery and the business development of medications intended for central nervous system (CNS) and neurological disorders. As an entrepreneur, Dr. Beyer has founded a biotech consulting company and helped launch a specialty pharmaceutical company focused on developing treatments for acute pain conditions. For more than a decade, Dr. Beyer worked in the Discovery Neuroscience group at Wyeth Pharmaceuticals, where he held multiple positions of increasing responsibility, including Head of Neurochemistry. During his time at Wyeth, he also led several drug discovery teams and managed a group of scientists that contributed to the submission of more than 30 INDs and generated supporting data for the commercialization and life-cycle management of Effexor(R) and Pristiq(R), two of the company's blockbuster medications. He is an editor of Next Generation Antidepressants and is co-founder of the journal Technology Transfer & Entrepreneurship. Dr. Beyer also serves as an adjunct faculty member at Thomas Jefferson University where he teaches Bioventure Management.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries